{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:38:43Z","timestamp":1648870723067},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.semerg.2017.03.008","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T07:31:13Z","timestamp":1498030273000},"page":"249-256","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An\u00e1lisis comparativo: Efectividad del tratamiento antitab\u00e1quico en la poblaci\u00f3n con comorbilidad psiqui\u00e1trica"],"prefix":"10.1016","volume":"44","author":[{"given":"R.","family":"Godoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Callejas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.I.","family":"Tornero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"T\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Rodr\u00edguez-Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2017.03.008_bib0155","unstructured":"The World Health Organization. The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992."},{"key":"10.1016\/j.semerg.2017.03.008_bib0160","unstructured":"WHO. International Classification of Diseases (ICD) [citado 7 Jul 2015]. Disponible en: http:\/\/www.who.int\/classifications\/icd\/en\/"},{"key":"10.1016\/j.semerg.2017.03.008_bib0165","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mentaldisorders. 5th de: DSM V. Washington, D.C.: American Psychiatric Association; 2013..","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.semerg.2017.03.008_bib0170","unstructured":"U.S. Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of Surgeon General, 1989. Rockville, Maryland. US DHHS, PHS, CDC, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. DHHS Publication No (CDC) 89-8411. 1989."},{"key":"10.1016\/j.semerg.2017.03.008_bib0175","unstructured":"The health consequences of smoking: A report of the Surgeon General. [Atlanta, Ga.]: Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Washington, D.C.: For sale by the Supt. of Docs., U.S. G.P.O., 2004 [citado 10 Ago 2015].Disponible en: http\/\/www.cdc.gov\/tobacco\/data_statistics\/sgr\/2004\/pdfs\/executiv esummary.pdf"},{"key":"10.1016\/j.semerg.2017.03.008_bib0180","unstructured":"World Health Organization. WHO Global Report: Mortality attributable to tobacco. Geneva, Switzerland: World Health Organization; 2012 [citado 7 Jul 2015]. Disponible en: http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241564434_eng.pdf?ua=1"},{"key":"10.1016\/j.semerg.2017.03.008_bib0185","series-title":"Tratado de tabaquismo.","first-page":"3","article-title":"El tabaquismo como enfermedad cr\u00f3nica. Visi\u00f3n global","author":"Jim\u00e9nez-Ruiz","year":"2012"},{"key":"10.1016\/j.semerg.2017.03.008_bib0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/13543784.15.2.107","article-title":"Neuropharmacology and potential efficacy of new treatments for tobacco dependence","volume":"15","author":"Fagerstr\u00f6m","year":"2006","journal-title":"Expert Opin Investig Drugs."},{"key":"10.1016\/j.semerg.2017.03.008_bib0195","unstructured":"Fiore MC, Ja\u00e9n CR, Baker TB, Bailey WC, Benowitz N, Curry S, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline, Rockville MD: US. Deparment of Health and Human Service. May 2008. Traducci\u00f3n al espa\u00f1ol: Gu\u00eda de Tratamiento del Tabaquismo. Jim\u00e9nez-Ruiz CA, Ja\u00e9n CR (coordinadores de la traducci\u00f3n). Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica. SEPAR; mayo 2010."},{"key":"10.1016\/j.semerg.2017.03.008_bib0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.medcli.2010.03.039","article-title":"La mortalidad atribuible al consumo de tabaco en Espa\u00f1a en 2006","volume":"136","author":"Banegas","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.semerg.2017.03.008_bib0205","unstructured":"WHO. Centro de Prensa [Internet]. Nota descriptiva n.o 339. July 2015. [citado 9 Ago 2015]. Disponible en: http:\/\/www.who.int\/mediacentre\/factsheets\/fs339\/es\/"},{"key":"10.1016\/j.semerg.2017.03.008_bib0210","unstructured":"WHO. Global Health Observatory Data [Internet]. Prevalence of tobacco use. [citado 9 Ago 2015]. Disponible en: http:\/\/www.who.int\/gho\/tobacco\/use\/en\/"},{"key":"10.1016\/j.semerg.2017.03.008_bib0215","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness: A population based prevalence study","volume":"284","author":"Lasser","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.semerg.2017.03.008_bib0220","series-title":"Tabaquismo y enfermedad psiqui\u00e1trica. Herramientas para la acci\u00f3n.","first-page":"67","article-title":"Tabaquismo en pacientes psiqui\u00e1tricos","author":"Serebrisky","year":"2012"},{"key":"10.1016\/j.semerg.2017.03.008_bib0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0213-9111(98)76465-9","article-title":"Prevalencia de trastornos mentales en la poblaci\u00f3n general de Catalunya","volume":"12","author":"Rajmil","year":"1998","journal-title":"Gac Sanit"},{"key":"10.1016\/j.semerg.2017.03.008_bib0230","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1157\/13086324","article-title":"Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-Espa\u00f1a","volume":"126","author":"Haro","year":"2006","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.semerg.2017.03.008_bib0235","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Portal estad\u00edstico del SNS [Intrenet]. Encuesta Nacional de Salud de Espa\u00f1a 2011\/2012. [citado 9 Ago 2015].Disponible en: http:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/encuestaNacional\/encuesta2011.htm"},{"key":"10.1016\/j.semerg.2017.03.008_bib0240","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess mortality of schizophrenia","volume":"177","author":"Brown","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.semerg.2017.03.008_bib0245","first-page":"129","article-title":"Psicolog\u00eda y asma","volume":"3","author":"Henry","year":"1993","journal-title":"Psicopatolog\u00eda (Madrid)"},{"key":"10.1016\/j.semerg.2017.03.008_bib0250","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/09638237.2014.924047","article-title":"Depression is linked to uncontrolled hypertension: A case-control study from Karachi, Pakistan","volume":"23","author":"Almas","year":"2014","journal-title":"J Ment Health."},{"key":"10.1016\/j.semerg.2017.03.008_bib0255","first-page":"44","article-title":"Peptic ulcer in patients with neurotic and affective disorders: Comorbidity, clinicoendoscopic and psychopathological features, approaches to therapy","volume":"81","author":"Garganeeva","year":"2009","journal-title":"Ter Arkh."},{"key":"10.1016\/j.semerg.2017.03.008_bib0260","first-page":"1413","article-title":"Mood disorders, psychopharmacology and thyroid hormones","volume":"132","author":"Quiroz","year":"2004","journal-title":"Rev Med Chile"},{"key":"10.1016\/j.semerg.2017.03.008_bib0265","series-title":"Tobacco and mental health: A literature review","author":"Brown","year":"2004"},{"key":"10.1016\/j.semerg.2017.03.008_bib0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00023210-199911020-00002","article-title":"Smoking cessation in individuals with depression","volume":"11","author":"Kinnunen","year":"1999","journal-title":"CNS Drugs."},{"key":"10.1016\/j.semerg.2017.03.008_bib0275","first-page":"71","article-title":"Abstinencia a los 3, 6, 9 y 12 meses en la consulta especializada de deshabituaci\u00f3n tab\u00e1quica del Complejo Hospitalario Universitario de Albacete","volume":"18","author":"Godoy Mayoral","year":"2016","journal-title":"Prev Tab."},{"key":"10.1016\/j.semerg.2017.03.008_bib0280","first-page":"1","article-title":"Continuous abstinence rates at 3, 6, 9 and 12 months in a smoking cessation unit at the Albacete University Hospital over 2 years","volume":"2","author":"Callejas Gonz\u00e1lez","year":"2015","journal-title":"Int J Respir Pulm Med."},{"key":"10.1016\/j.semerg.2017.03.008_bib0285","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1157\/13087715","article-title":"Abstinencia de tabaquismo tras 12 meses de seguimiento en una unidad de tabaquismo integral","volume":"126","author":"Pascual-Lled\u00f3","year":"2006","journal-title":"Med Clin."},{"key":"10.1016\/j.semerg.2017.03.008_bib0290","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/11594450-000000000-00000","article-title":"Psychiatric adverse events associates with varenicline: An intensive postmarketing prospective cohort study in New Zealand","volume":"34","author":"Harrison-Woolrych","year":"2011","journal-title":"Drug Saf."},{"key":"10.1016\/j.semerg.2017.03.008_bib0295","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2010.12.005","article-title":"A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo","volume":"69","author":"Garza","year":"2011","journal-title":"Biol Psychiatry."},{"key":"10.1016\/j.semerg.2017.03.008_bib0300","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359317301065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359317301065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T12:21:58Z","timestamp":1569500518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359317301065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1138359317301065"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2017.03.008","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An\u00e1lisis comparativo: Efectividad del tratamiento antitab\u00e1quico en la poblaci\u00f3n con comorbilidad psiqui\u00e1trica","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2017.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}